Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.0%
Tue, 16 Jul 9:39

STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.0%Image source: alexsl/www.istockphoto.com

STRIDES PHARMA SCIENCE share price has zoomed 4% and is presently trading at Rs 944.0.

Meanwhile, the BSE HEALTHCARE index is at 38,800.4 .

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 4.2%) and GSK Pharma (up 3.5%).

MAX HEALTHCARE INSTITUTE (down 1.2%) and IPCA Labs (down 0.8%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 443.1 to Rs 944.0, registering a gain of Rs 500.9 (up 113.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 26,286.8 to 38,800.4, registering a gain of 47.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 108.4%), Cadila Healthcare (up 99.9%) and Lupin (up 94.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 80,809.7 (up 0.2%).

The top gainers among the BSE Sensex today are Tata Steel (up 1.2%) and M&M (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,636.1 (up 0.2%). BPCL and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,393.9 to 80,809.7, registering a gain of 15,415.8 points (up 23.6%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit grew 119.9% YoY to Rs 590 million for the quarter ended March 2024, compared to a profit of Rs 268 million a year ago. Net sales rose 9.9% to Rs 10,840 million during the period as against Rs 9,864 million in January-March 2023.

For the year ended March 2023, STRIDES PHARMA SCIENCE reported 51.3% increase in net profit to Rs -2,309 million compared to net loss of Rs 4,743 million during FY22. Revenue of the company grew 20.1% to Rs 36,884 million during FY23.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 319.0.


Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.0%". Click here!